Australia markets closed

Evelo Biosciences, Inc. (EVLO)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0005-0.0401 (-98.77%)
At close: 10:37AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
81,351
78,554
83,643
69,616
63,128
Selling general and administrative
33,587
29,912
31,753
22,270
23,229
Total operating expenses
114,938
108,466
115,396
91,886
86,357
Operating income or loss
-114,938
-108,466
-115,396
-91,886
-86,357
Interest expense
3,845
4,672
3,612
2,109
-
Total other income/expenses net
-372
-459
-2,740
738
26
Income before tax
-119,155
-113,597
-121,748
-93,257
-85,282
Income tax expense
483
930
428
409
190
Income from continuing operations
-119,638
-114,527
-122,176
-93,666
-85,472
Net income
-119,638
-114,527
-122,176
-93,666
-85,472
Net income available to common shareholders
-119,638
-114,527
-122,176
-93,666
-85,472
Basic EPS
-15.64
-26.20
-46.20
-47.40
-53.40
Diluted EPS
-15.64
-26.20
-46.20
-47.40
-53.40
Basic average shares
4,956
4,358
2,646
1,974
1,602
Diluted average shares
4,956
4,358
2,646
1,974
1,602